This browser doesn't support Spotify Web Player. Switch browsers or download Spotify for your desktop.

PeerVoice Clinical Pharmacology Audio

By PeerVoice

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

  1. 1.
    Targeting Remission in Auto-Inflammatory Diseases With Anti─IL-1β05/24/2019
    46:04
  2. 2.
    Imagining a World Without Hepatitis C Virus: A Call to Action05/22/2019
    10:03
  3. 3.
    Aiming Higher in Advanced Cutaneous Squamous Cell Carcinoma: Experts Evaluate the Evidence for Immunotherapy05/17/2019
    28:35
  4. 4.
    Emerging ‘Tumour-Agnostic’ Oncology Treatment: The Role of the Pathologist in Identifying Neurotrophic Tyrosine Kinase Gene Fusions05/03/2019
    25:58
  5. 5.
    Merging Clinical Trial Results and Reality: The Real-World Implications of Androgen Receptor Antagonists for Non–Metastatic Castration-Resistant Prostate Cancer04/29/2019
    29:06
  6. 6.
    A Case for Clarity: Putting the Latest Recommendations for IPF Into Context04/22/2019
    10:09
  7. 7.
    Should We Be Treating Ulcerative Colitis as a Progressive Disease?03/29/2019
    15:50
  8. 8.
    Learning From the Literature: The Latest Evidence on JAK Inhibitors for RA03/20/2019
    16:27
  1. 9.
    Optimising Outcomes for Young Women With Breast Cancer: The Role of Adjuvant Ovarian Suppression03/15/2019
    21:05
  2. 10.
    A Closer Look at Safety of Glucose-Lowering Therapy02/27/2019
    18:46
  3. 11.
    Managing Patients With HER2-Low Breast Cancer02/19/2019
    14:29
  4. 12.
    Is There a Cardio-Oncologist in the House? Managing Risk for VTE and Stroke Due to AF in Patients With Cancer02/07/2019
    19:41
  5. 13.
    Do You Know JAK? Updates From Chicago on Rheumatoid Arthritis Management02/05/2019
    18:59
  6. 14.
    Spotlight on Disease Burden and Quality of Life in Atopic Dermatitis: Are We Missing the Big Picture?01/07/2019
    11:38
  7. 15.
    A High Index of Suspicion: The Key to Early Diagnosis and Treatment of Atypical Haemolytic Uraemic Syndrome01/02/2019
    22:16
  8. 16.
    Biomarkers in Lung Cancer: Targeting the Right Patient With the Right Therapy11/26/2018
    1:14:45
  9. 17.
    How a New Understanding of Severe Asthma Is Changing Treatment Paradigms11/23/2018
    19:37
  10. 18.
    Improving Outcomes in Type 2 Diabetes: Focus on Cardiovascular and Renal Safety11/06/2018
    1:13:39
  11. 19.
    Stroke Prevention in Atrial Fibrillation: Lessons from Real-World Studies10/24/2018
    21:59
  12. 20.
    Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa10/17/2018
    1:10:30
  13. 21.
    Navigating the Road to Psoriasis Control in Women: Strategies to Optimise the Reproductive Journey10/15/2018
    1:06:51
  14. 22.
    Endotyping Severe Asthma: For Which Patients and Why?10/12/2018
    16:41
  15. 23.
    Forging a Path to RA Treatment: Exploring the Potential for IL-6 Inhibitors10/08/2018
    16:23
  16. 24.
    Keeping the Future in Sight in Acute Schizophrenia Care: The Role of Long-Acting Injectables10/03/2018
    8:11
  17. 25.
    Targeting IL1-β Toward Remission in Auto-Inflammatory Diseases – Expert Perspectives on Recent Clinical Data10/01/2018
    54:37
  18. 26.
    Paroxysmal Nocturnal Haemoglobinuria: Complementing Current Knowledge To Improve Outcomes09/28/2018
    28:08
  19. 27.
    Best Practices for Use of Proteasome Inhibitors in the Treatment of Relapsed/Refractory Multiple Myeloma09/24/2018
    19:11
  20. 28.
    Learning From the Literature: New Data for Improving CF Management and Patient Outcomes09/17/2018
    20:05
  21. 29.
    Spotlight on Adult ADHD and Substance Use Disorder: Identifying and Managing Difficult Cases09/10/2018
    15:54
  22. 30.
    Type 2 Inflammation in Severe Asthma: What Does It Mean Today?09/05/2018
    14:54
  23. 31.
    Balancing Safety With Stroke Prevention in High-Risk Patients With AF08/31/2018
    15:12
  24. 32.
    Conversations on Steps to Biologic Therapy for Atopic Dermatitis: Patient and Dermatologist Insights for European Practice08/29/2018
    17:51
  25. 33.
    Best Practices in Managing CML08/17/2018
    17:59
  26. 34.
    Clinical Updates: New Pathways and Strategies in Small-Cell Lung Cancer07/04/2018
    19:09
  27. 35.
    Exploring Treatment Choices in Crohn’s Disease: Using Current Evidence to Optimize Outcomes07/02/2018
    16:46
  28. 36.
    Getting Under the Skin in Atopic Dermatitis: Evolving Treatment Approaches06/26/2018
    18:00
  29. 37.
    Newer Targeted Therapies for Rheumatoid Arthritis: Weighing the Pros and Cons06/19/2018
    14:50
  30. 38.
    An Integrative Approach to the Management of Spondyloarthritis: Improving Clinical Outcomes and Quality of Life06/13/2018
    24:16
  31. 39.
    Improving Clinical Management of Patients with Heart Failure06/01/2018
    15:08
  32. 40.
    Locally Advanced BCC: Selecting the Right Option to Optimise Outcomes in Your Patients05/11/2018
    18:38
  33. 41.
    Improving the Long-Term Treatment Plan for Patients With Metastatic Pancreatic Cancer: Insights From San Francisco05/09/2018
    8:25
  34. 42.
    Conundrums in Ulcerative Colitis: Matching the Right Biologic to the Right Patient05/04/2018
    16:16
  35. 43.
    The Treatment Plan for Patients With Nonmetastatic Prostate Cancer in Canada: Optimizing the Journey From The Beginning05/03/2018
    26:10
  36. 44.
    Emerging Biomarkers in Small-Cell Lung Cancer: A New Era04/30/2018
    16:44
  37. 45.
    Expert Perspectives on Managing Complex Patients With Spondyloarthritis04/27/2018
    21:29
  38. 46.
    Considering the Possibility of Psoriatic Arthritis in Patients With Psoriasis04/25/2018
    16:02
  39. 47.
    Cardiovascular and Renal Safety in Type 2 Diabetes: What Clinicians Need to Know04/20/2018
    20:44
  40. 48.
    Protecting Adolescents and Adults From Vaccine Preventable Bacterial Diseases: A Look at Serogroup B Meningococcal Disease and Pneumococcal Diseases04/18/2018
    16:54
  41. 49.
    Treating Rheumatoid Arthritis and Spondyloarthritis to Target: What Are We Missing in Clinical Practice?04/16/2018
    21:27
  42. 50.
    Looking Beyond the Skin and Joints in Psoriatic Arthritis: A Comprehensive Approach to Improving Patient Outcomes04/13/2018
    17:26
  43. 51.
    Improving Outcomes in Later Lines of Therapy for Metastatic Colorectal Cancer04/11/2018
    18:48
  44. 52.
    New Strategies, New Targets: The Evolving Landscape in Driver-Mutation–Positive Advanced NSCLC04/09/2018
    11:04
  45. 53.
    Von der Krankheitsentstehung zu klinischen Strategien für autoinflammatorische und Autoimmunerkrankungen: Welche Rolle spielen Interleukine?04/06/2018
    40:51
  46. 54.
    Enthesitis in Psoriatic Arthritis and Spondyloarthritis: Targeting Pathophysiologic Mechanisms to Optimise Patient Management04/05/2018
    21:05
  47. 55.
    Defining the Optimal Respiratory Syncytial Virus Infection Management Strategy: Applying Health Economics to Improve Patient Outcomes04/02/2018
    19:07
  48. 56.
    Addressing the Management Challenges of JIA-Associated Uveitis: From Screening to Treatment03/19/2018
    17:32
  49. 57.
    Modern Management of Patients With Rheumatic Diseases: What Pharmacists Need to Know About Biologic Therapies03/15/2018
    16:21
  50. 58.
    Improving Clinical Management of Patients With Heart Failure02/23/2018
    15:08
  51. 59.
    Understanding the Role of Residual Function Mutations and the Potential of Targeted Therapies in Cystic Fibrosis02/19/2018
    14:38
  52. 60.
    An Integrative Approach to the Management of Spondyloarthritis: Improving Clinical Outcomes and Quality of Life02/14/2018
    24:16
  53. 61.
    Does Dry Eye Matter? Considerations for Clinical Practice02/09/2018
    17:43
  54. 62.
    Synergistic Approaches in Metastatic Melanoma Treatment: The Rationale for Combination Immunotherapy02/05/2018
    20:50
  55. 63.
    The Experts' Views on Tackling Challenges in the Management of Noninfectious Uveitis02/02/2018
    27:07
  56. 64.
    AE Monitoring and Management Strategies for Patients With Metastatic Breast Cancer Receiving Treatment With CDK4/6 Inhibitors01/29/2018
    13:55
  57. 65.
    Journal Club: Review of Recent Data for the Treatment of Stage III, Locally Advanced, Unresectable NSCLC01/22/2018
    13:41
  58. 66.
    SGLT2 Inhibitors: From A1C to Cardiac and Renal Outcomes01/18/2018
    17:21
  59. 67.
    A New Paradigm Shift in IBD? Clinical Advances in Applying a Treat-to-Target Strategy01/06/2018
    17:53
  60. 68.
    Elevating the Patient Experience in Axial Spondyloarthritis and Psoriatic Arthritis: Can a Treat-to-Target Approach Improve Long-Term Outcomes?01/03/2018
    21:42
  61. 69.
    Managing Patients With Overactive Bladder in Canada: Evaluating Recent Evidence12/29/2017
    17:07
  62. 70.
    Can We Improve Our Treatment of Patients With Spondyloarthritis? A Congress Update From San Diego12/27/2017
    17:57
  63. 71.
    Individualizing Care for Optimal Patient Outcomes in Metastatic Melanoma12/22/2017
    9:26
  64. 72.
    Achieving HCV Elimination in Australia: The Pan-Genotypic Treatment Era12/20/2017
    18:13
  65. 73.
    Respiratory Syncytial Virus: Should We Identify Paediatric Patients at Risk for Severe Disease?12/15/2017
    1:00:59
  66. 74.
    Improving QoL in Pre-treated Advanced Breast Cancer: What Are Our Options?12/13/2017
    13:44
  67. 75.
    Resistant Gram-Negative and Gram-Positive Bacterial Infections: What Physicians Need to Know12/11/2017
    18:42
  68. 76.
    Back to Basics: What You Need to Know to Identify BCC in Your Patients12/04/2017
    8:14
  69. 77.
    Optimising Outcomes in Advanced Melanoma: The Role of the Pathologist12/01/2017
    16:29
  70. 78.
    Practical Implications of Recent Clinical Advances on the Treatment of Spondyloarthritis: Updates From Madrid11/27/2017
    23:10
  71. 79.
    Exploring Effective Anticoagulation Options for Patients With AF Undergoing PCI11/13/2017
    10:30
  72. 80.
    Optimizing Strategies for Switching Antipsychotics in Schizophrenia11/10/2017
    11:07
  73. 81.
    Expert Perspectives: Weighing the Evidence for Current and Emerging Therapies in the Management of Advanced Renal Cell Carcinoma10/30/2017
    33:09
  74. 82.
    Cases in IPF From Diagnosis Through Treatment10/20/2017
    18:26
  75. 83.
    Multidisciplinary Perspectives on the Future of Pancreatic Cancer Treatment Through the Disease Course: Piecing the Information Together10/18/2017
    1:01:59
  76. 84.
    Journal Club: ORAL Strategy—New Insights on Biologic Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis10/11/2017
    20:35
  77. 85.
    Optimising Safety of Oral Anticoagulation in Patients With Atrial Fibrillation: How Experts Overcome Clinical Challenges10/04/2017
    16:54
  78. 86.
    Individualising Therapy for SPAF: An Evidence-based Approach to Management10/02/2017
    9:33
  79. 87.
    Managing Idiopathic Pulmonary Fibrosis: Comprehensive Approaches Across the Disease Continuum09/25/2017
    18:18
  80. 88.
    Treating Adult ALL in Canada: Expert Guidance on Updated Treatment Protocols09/22/2017
    11:15
  81. 89.
    Current and Emerging Therapies in the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck09/18/2017
    15:19
  82. 90.
    An Evolving Era in the Treatment of Recurrent Ovarian Cancer: How Do We Optimise Use of PARP Inhibitors?09/15/2017
    19:16
  83. 91.
    Expert Perspectives on Management of EGFR-Mutated NSCLC: Overcoming Resistance to Ensure Active Lines of Therapy09/13/2017
    24:48
  84. 92.
    The Evolving Landscape for the Treatment of Carcinoid Syndrome09/11/2017
    17:26
  85. 93.
    Managing Bleeding and Urgent Procedures in Patients Receiving NOACs: How Will Reversal Agents Impact Practice?09/08/2017
    9:17
  86. 94.
    Overcoming the Roadblocks to HCV Elimination: Is There a Case for Treatment Simplification?09/01/2017
    19:45
  87. 95.
    Using the Data to Optimize Front-Line Immunotherapy in Advanced Melanoma08/30/2017
    18:22
  88. 96.
    Updates From Madrid: New Findings on IL-6 Inhibitors for Treatment of Rheumatoid Arthritis08/16/2017
    14:54
  89. 97.
    Integrating Novel Agents Into Treatment of Relapsed/Refractory Multiple Myeloma: Addressing Current Challenges and Unmet Needs in Brazil08/09/2017
    10:53
  90. 98.
    Current Evidence for Overactive Bladder: Optimizing Treatment Strategies With Antimuscarinics and Beta-3 Adrenoceptor Agonists08/07/2017
    16:50
  91. 99.
    Integrating Medical and Surgical Approaches to Hidradenitis Suppurativa Management08/04/2017
    20:50
  92. 100.
    Care Considerations in PsO, PsA, and AS: Understanding Key Comorbidities and Treating Patients Who Are At-Risk for IBD05/29/2017
    15:39

Listen to PeerVoice Clinical Pharmacology Audio now.

Listen to PeerVoice Clinical Pharmacology Audio in full in the Spotify app